Axxcess Wealth Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.55M Sell
12,305
-979
-7% -$129K 0.02% 436
2026
Q1
$1.85M Sell
13,284
-1,242
-9% -$174K 0.06% 196
2025
Q4
$1.78M Buy
14,526
+1,155
+9% +$140K 0.03% 396
2025
Q3
$1.48M Buy
13,371
+2,953
+28% +$336K 0.03% 372
2025
Q2
$1.16M Sell
10,418
-1,568
-13% -$167K 0.03% 395
2025
Q1
$1.34M Sell
11,986
-1,314
-10% -$136K 0.04% 329
2024
Q4
$1.23M Sell
13,300
-998
-7% -$89.9K 0.03% 368
2024
Q3
$1.2M Sell
14,298
-5,448
-28% -$416K 0.03% 355
2024
Q2
$1.35M Buy
19,746
+1,830
+10% +$122K 0.04% 323
2024
Q1
$1.31M Buy
17,916
+3,521
+24% +$271K 0.04% 323
2023
Q4
$1.17M Sell
14,395
-504
-3% -$39.2K 0.03% 327
2023
Q3
$1.12M Buy
14,899
+5,674
+62% +$436K 0.04% 299
2023
Q2
$711K Sell
9,225
-7,507
-45% -$599K 0.05% 281
2023
Q1
$1.39M Buy
16,732
+1,059
+7% +$87.7K 0.11% 182
2022
Q4
$1.35M Buy
15,673
+6,910
+79% +$547K 0.11% 177
2022
Q3
$541K Buy
8,763
+4,158
+90% +$262K 0.05% 304
2022
Q2
$285K Sell
4,605
-3,873
-46% -$240K 0.03% 409
2022
Q1
$504K Buy
8,478
+2,006
+31% +$128K 0.04% 356
2021
Q4
$470K Buy
+6,472
New +$446K 0.03% 375

Other funds holding GILD

Axxcess Wealth Management's GILD Position: Q2 2026 in Review

Axxcess Wealth Management reduced its Gilead Sciences (GILD) stake by 7.4% in Q2 2026, selling an estimated $129K and leaving 12,305 shares worth $1.55M. The position accounts for 0.02% of the portfolio, ranked #436.

Axxcess Wealth Management first reported a position in GILD in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.85M in Q1 2026. 1,032 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Axxcess Wealth Management held 12,305 shares of Gilead Sciences worth $1.55M as of Q2 2026.
  • Axxcess Wealth Management sold 979 Gilead Sciences shares in Q2 2026, an estimated $129K.
  • Gilead Sciences made up 0.02% of Axxcess Wealth Management's portfolio in Q2 2026, its #436 holding.
  • Axxcess Wealth Management first reported a position in Gilead Sciences in Q4 2021 and has held it in 19 quarters since.
  • Axxcess Wealth Management's Gilead Sciences position peaked at $1.85M in Q1 2026.
  • 1,032 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Axxcess Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.